RxDoctor Payments Data

Gerri Norman

Psychiatric/Mental Health · Fredericksbrg, TXNPI 1942478292

Payments from drug & device makers

$1,102in general payments, 2019–2025

Across 53 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$362
  • Neurocrine Biosciences, Inc.$258
  • Otsuka America Pharmaceutical, Inc.$147
  • Johnson & Johnson$109
  • Lundbeck LLC$92
  • E.r. Squibb & Sons, L.L.C.$61
  • plus $74 from 3 others

What the payments were for

  • Food & beverage$1,102100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,102 in reported general payments places this provider in the 60th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$11,224
Medicare patients
36
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine22$105,305
AustedoDeutetrabenazine12$66,883
Invega SustennaPaliperidone Palmitate12$42,357
RexultiBrexpiprazole24$36,678
Modafinil12$12,963
Aripiprazole129$12,914
Lurasidone Hcl30$8,037
Venlafaxine Hcl ErVenlafaxine Hcl43$1,507
Duloxetine Hcl91$1,273
Haloperidol29$1,030
Quetiapine Fumarate60$775
Clozapine24$697
Olanzapine62$688
Trazodone Hcl114$678
Benztropine Mesylate43$567

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo$362$172,18834 claims
Johnson & JohnsonInvega Sustenna$109$42,35712 claims
Otsuka America Pharmaceutical, Inc.Rexulti$147$36,67824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Fredericksbrg

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →